MAPT and Alzheimer disease: In conclusion, VR tau‐PET‐negative individuals with AD dementia are older and have less cognitive decline than VR tau‐PET‐positive AD patients, demonstrating a less severe disease trajectory than tau‐PET‐positive individuals with AD dementia.